Quantum Biopharma Ltd. Files May 2025 6-K Report

Ticker: QNTM · Form: 6-K · Filed: May 16, 2025 · CIK: 1771885

Quantum Biopharma Ltd. 6-K Filing Summary
FieldDetail
CompanyQuantum Biopharma Ltd. (QNTM)
Form Type6-K
Filed DateMay 16, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, corporate-update, foreign-issuer

TL;DR

Quantum Biopharma filed its May 6-K, confirming 20-F filings.

AI Summary

Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 16, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing is for the month of May 2025 and indicates the company files annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's ongoing reporting status and corporate information.

Risk Assessment

Risk Level: low — This is a routine filing that does not contain new material financial or operational information.

Key Players & Entities

  • Quantum Biopharma Ltd. (company) — Filer of the report
  • FSD Pharma Inc. (company) — Former name of the registrant
  • May 16, 2025 (date) — Filing date
  • Toronto, Ontario (location) — Company headquarters
  • Form 20-F (document) — Annual report filing type
  • Form 6-K (document) — Report type

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.

What is the former name of Quantum Biopharma Ltd.?

The former name of Quantum Biopharma Ltd. was FSD Pharma Inc., with a date of name change on March 27, 2019.

Where is Quantum Biopharma Ltd. headquartered?

Quantum Biopharma Ltd. is headquartered at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.

Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?

Quantum Biopharma Ltd. indicates that it files annual reports under cover of Form 20-F.

What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?

The Standard Industrial Classification code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 16, 2025 regarding Quantum Biopharma Ltd. (QNTM).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.